血小板由来増殖因子受容体β阻害剤は,腫瘍壊死因子関連アポトーシス誘発性リガンド(TRAIL)の感受性を増大させる イマチニブとTRAILの2剤併用療法
2010
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
Old Web
English
Sign In
Email Address
acemap@cs.sjtu.edu.cn
- CCF Conference Analysis
- Map Galaxy
- Academic Report
- What's New
© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.